Diabetes Care Devices - Fiji | Statista Market Forecast

In Fiji, revenue in the Diabetes Care Devices market market is projected to reach US$1.07m in 2024.
The revenue is anticipated to exhibit an annual growth rate (CAGR 2024-2029) of 12.31%, leading to a market volume of US$1.91m by 2029.
In a global context, the highest revenue is expected to be generated the United States, amounting to US$11.71bn in 2024.
Fiji is witnessing a growing demand for innovative diabetes care devices, driven by increasing awareness of diabetes management and healthcare accessibility.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Fiji is witnessing considerable growth, fueled by rising prevalence of diabetes, increased health awareness, and advancements in technology, which enhance accessibility and effectiveness of diabetes management solutions for patients.

Customer preferences: In Fiji, there is a noticeable shift towards personalized diabetes management solutions as consumers increasingly prioritize tailored healthcare options. The integration of mobile health applications and connected devices is becoming popular, allowing individuals to track their glucose levels and receive real-time feedback. Additionally, younger generations are embracing technology, seeking devices that offer convenience and data sharing capabilities with healthcare providers. This trend reflects a broader cultural emphasis on proactive health management and the desire for greater involvement in personal health decisions.

Trends in the market: In Fiji, the Diabetes Care Devices Market is experiencing a significant shift towards innovative, user-friendly technologies that empower patients to manage their condition more effectively. The rise of continuous glucose monitoring systems and smart insulin pens is notable, as these devices provide real-time data and enhance adherence to treatment regimens. Additionally, partnerships between tech companies and healthcare providers are fostering the development of integrated platforms that facilitate data sharing. This trend not only improves patient outcomes but also opens new avenues for collaboration among industry stakeholders, driving advancements in diabetes care solutions.

Local special circumstances: In Fiji, the Diabetes Care Devices Market is shaped by the unique geographical dispersion of its islands, which can complicate access to healthcare services. Cultural attitudes towards health and wellness also play a significant role, as traditional practices coexist with modern medical approaches. Furthermore, regulatory frameworks are evolving to accommodate innovative technologies, facilitating faster approvals for new devices. These factors collectively influence the adoption and integration of diabetes management solutions, ensuring that they are tailored to the specific needs of the Fijian population.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Fiji is influenced by several macroeconomic factors, including the nation's economic stability, healthcare expenditure, and global economic trends. As Fiji's economy gradually recovers, increased investment in healthcare infrastructure is expected to enhance the availability of diabetes management solutions. Additionally, fiscal policies aimed at improving public health can drive the adoption of innovative diabetes care devices. Global trends, such as rising diabetes prevalence and advancements in medical technology, further accelerate the demand for effective diabetes management tools, ensuring that local solutions meet the unique needs of the Fijian population.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.